These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Aspirin response and failure in diabetic patients with cardiovascular disease. Yan Y; Phillips DR Curr Opin Pharmacol; 2005 Apr; 5(2):190-7. PubMed ID: 15780830 [TBL] [Abstract][Full Text] [Related]
30. Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy. Spallarossa P; Barsotti A; Cordera R; Ghigliotti G; Maggi D; Brunelli C J Endocrinol Invest; 2004 May; 27(5):485-95. PubMed ID: 15279085 [TBL] [Abstract][Full Text] [Related]
31. Harnessing the incretin system beyond glucose control: potential cardiovascular benefits of GLP-1 receptor agonists in type 2 diabetes. Cariou B Diabetes Metab; 2012 Oct; 38(4):298-308. PubMed ID: 22672960 [TBL] [Abstract][Full Text] [Related]
32. Potential Effects of Nonsteroidal Anti-Inflammatory Drugs in the Prevention and Treatment of Type 2 Diabetes Mellitus. Bellucci PN; González Bagnes MF; Di Girolamo G; González CD J Pharm Pract; 2017 Oct; 30(5):549-556. PubMed ID: 27194069 [TBL] [Abstract][Full Text] [Related]
34. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes. Donath MY Diabetologia; 2016 Apr; 59(4):679-82. PubMed ID: 26868493 [TBL] [Abstract][Full Text] [Related]
35. Diabetes medications and cardiovascular disease: at long last progress. Lupsa BC; Inzucchi SE Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):87-93. PubMed ID: 29369916 [TBL] [Abstract][Full Text] [Related]
36. Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control. Sarafidis PA; Bakris GL QJM; 2006 Jul; 99(7):431-6. PubMed ID: 16766516 [TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy of metformin against insulin resistance parameters: sinking the iceberg. Zimmet P; Collier G Drugs; 1999; 58 Suppl 1():21-8; discussion 75-82. PubMed ID: 10576521 [TBL] [Abstract][Full Text] [Related]
38. Investigation of the anti-inflammatory effects of safranal on high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Hazman Ö; Ovalı S Inflammation; 2015; 38(3):1012-9. PubMed ID: 25411096 [TBL] [Abstract][Full Text] [Related]
39. Type II diabetes mellitus. Edelman SV Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190 [TBL] [Abstract][Full Text] [Related]